Key facts
- This page summarizes Peter Linde's Form 4 filing for Morphic Holding, Inc..
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Sep 2021, 19:04.
Peter Linde - 16 Sep 2021 Form 4 Insider Report for Morphic Holding, Inc.
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- N/A
- Reported as of
- 16 Sep 2021
- Net transaction value
- -$266,037
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2021, 19:04:08 UTC
- Prior SEC filing
- 03 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Farrell as attorney-in-fact for Peter Linde
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Peter Linde filed Form 4 for Morphic Holding, Inc. on 17 Sep 2021.
Change
- Previous filing in this sequence was filed on 03 Jun 2021.
- Current net transaction value: -$266,037.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MORF
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +10,378
- Change %
- +212%
- Price
- Shares after
- 15,272
- Date
- 16 Sep 2021
- Ownership
- Direct
- Footnotes
- F1, F2
MORF
transaction
Common Stock
Sale
- Transaction value
- $6,429
- Shares
- -100
- Change %
- -0.65%
- Price
- $64.29
- Shares after
- 15,172
- Date
- 16 Sep 2021
- Ownership
- Direct
- Footnotes
- F3
MORF
transaction
Common Stock
Sale
- Transaction value
- $217,803
- Shares
- -3,276
- Change %
- -22%
- Price
- $66.48
- Shares after
- 11,896
- Date
- 16 Sep 2021
- Ownership
- Direct
- Footnotes
- F3, F4
MORF
transaction
Common Stock
Sale
- Transaction value
- $41,805
- Shares
- -624
- Change %
- -5.2%
- Price
- $67.00
- Shares after
- 11,272
- Date
- 16 Sep 2021
- Ownership
- Direct
- Footnotes
- F3, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MORF
transaction
Derivative
Restricted Stock Unit (RSU
Options Exercise
- Transaction value
- $0
- Shares
- -10,378
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 16 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,378
- Exercise price
- Footnotes
- F1, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
Footnote F2
Includes 294 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2021.
Footnote F3
Represents the aggregate number of shares sold by the reporting person to cover taxes and fees due upon the release and settlement of the RSUs. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
Footnote F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.89 to $66.8825 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.915 to $67.105 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.